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Background: Pulmonary tuberculosis remains an important public health problem globally and one of the most
prevalent infectious diseases in Sri Lanka. It can cause a wide variety of complications but hematological manifestations
are rare. According to our literature survey, this is the first reported case of the disease associated with deep vein
thrombosis in Sri Lanka.
Case presentation: A 37 year old Sri Lankan Sinhalese female presented with fever of one month’s duration with
productive cough and two weeks painless left lower limb swelling. Chest X-ray showed bilateral inflammatory shadows
with a cavitatory lesion on the right apical region. A computed tomographic pulmonary angiography scan excluded
pulmonary embolism. She had rising mycoplasma antibody titre (four fold). Acute deep vein thrombosis of the
left lower limb was confirmed by venous duplex. Pulmonary tuberculosis was confirmed with positive culture for
Mycobacterium tuberculosis. She was treated with clarythromycin, enoxaparin, warfarin and anti tuberculus drugs.
It was difficult to maintain her International Normalizing Ratio in the therapeutic range due to drug interactions
and poor compliance. At five months of presentation she died of massive pulmonary embolism.
Conclusion: Our case emphasizes that patients with severe pulmonary tuberculosis are at risk of developing
thromboembolism and superadded infections. It should be noted that even though starting anti tuberculosis
drugs improved haemostatic disturbances, achieving the target International Normalizing Ratio was difficult due
to drug interactions. Therefore these patients should be closely followed up to prevent complications and death
from pulmonary embolism.
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According to the WHO (World Health Organization),
every second a person gets infected by the tuberculus
bacillus in the world. As of today one third of world's
population has been infected by this bacillus. Tubercu-
losis is the commonest cause for death in adults with
infectious diseases despite the availability of drugs.
Therefore it is a health problem globally. Tuberculosis can
cause a wide variety of complications but hematological
complications are rarely demonstrated in pulmonary tu-
berculosis. Some authors believe that the risk of develop-
ing deep vein thrombosis (DVT) increases with the
severity of this disease [1].* Correspondence: udayapralapanawa@yahoo.com
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unless otherwise stated.DVT can be the presenting feature of tuberculosis that
occurs late in the course of this disease or in patients on
anti tuberculosis treatment [2-4]. Here we present a case
of pulmonary tuberculosis presented to us with DVT in
the lower limb. Even though tuberculosis is one of most
prevalent infectious disease in Sri Lanka and to the best
of our knowledge after through literature searched, this
is to be the first reported case of pulmonary tuberculosis
(PTB) presenting with DVT.
Case presentation
A 37 year old Sri Lankan Sinhalese female presented to
the Teaching Hospital Peradeniya, Sri Lanka with fever
of one month duration. She complaints of productive
cough of three week’s duration with no history of haem-
optysis or breathlessness. Fever was associated with an-
orexia and weight loss. She noticed painless left lowerntral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Figure 1 (Chest x-ray on Day 1 of admission). Opacification
predominantly involving the right mid zones. There are adjacent
nodular opacities with large cavitatory lesion at the right upper
zone. Right heart border is obliterated. Mediastinum has shifted to
right. No pleural effusions or bony erosions.
Figure 2 (Chest x-ray on Day 3 of admission). Extent of
opacification increased with coalescing of nodules (Right > Left).
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extended up to the upper thigh three days before pre-
senting to the hospital. She did not have any history of
joint pain, photosensitivity rash or alopecia, deep vein
thrombosis, recurrent abortion, intrauterine death or
thrombotic stroke. She did not have risky behavior or
history of immobilization. She was neither an alcoholic
nor smoker and denied use of oral contraceptives.
On examination she was febrile and pale but not
tachypnic or tachycardic. She was normotensive and the
pulse oxymetric reading was 96% on air. Chest ausculta-
tion revealed scattered bilateral coarse crepitations
which were more on the right side. Abdominal examin-
ation was normal including per vaginal and per rectal
examination. Cardiovascular and neurological examina-
tions were clinically normal. Her left lower limb was swol-
len up to the groin and there was tenderness over the calf.
No evidence of cellulites was detected. On the third day
of hospital admission she became dyspnoic with wide
spread right sided coarse crepitations and reduced pulse
oximetric reading of 93% on air.
Laboratory finding on admission revealed relative neu-
trophil leucocytosis, hypochromic microcytic anaemia
(haemoglobin 10.5 g %) with high Erythrocyte sedimen-
tation rate (ESR) and C-reactive protein (CRP). The
blood picture revealed, hypochromic microcytic anaemia
with toxic granules and vacuolations in neutrophils indi-
cating severe bacterial infection. Her renal and liver
functions were normal. Chest X-ray on admission
showed bilateral inflammatory shadows with a cavitatory
lesion on the right apical region. Chest X-ray on the
third day revealed wide spread inflammatory shadows
involving whole right sided lung field (Figures 1 and 2).
Computed tomographic pulmonary angiogram (CTPA)
was done on the third day to exclude pulmonary embol-
ism. She had rising mycoplasma antibody titre (four
fold) with normal reticulocyte count and Coombs’ test
was negative. Her fasting blood sugar and lipid profile
were normal. Human immune deficiency virus (HIV)
and Hepatitis B and C viral infections were excluded.
Antinuclear antibody (ANA) was negative. Acute DVT
of the left lower limb causing total occlusion of veins
below the internal iliac vein was confirmed by venous
duplex. Ultrasound scan of abdomen and pelvis was nor-
mal with no lymphadinopathy. Mycobacterium tubercu-
lulosis bacillus was detected by sputum AFB (Acid fast
Bacilli) staining and confirmed by culture. She was ini-
tially treated with intravenous clarythromycin for myco-
plasma infection and was started on subcutaneous
enoxaparin and oral warfarin for DVT. Enoxaparin was
discontinued once the target International Normalizing
Ratio (INR) was achieved. Initial warfarin 7 mg once a
day could maintain her INR within 2–2.5. Once tubercu-
losis infection was confirmed, anti tuberculus treatment
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With initiation of ATT, a titrated warfarin dose up to
15 mg per day was given to maintain therapeutic INR.
One month after initiating warfarin, a repeat duplex scan
was done and revealed little blood flow without signifi-
cant recanalisation or further extension of the thrombus.
Two months after the commencement of ATT, throm-
bophilia screening according to the National Health
Services (NHS) United Kingdom Foundation Trust
guidelines for thrombophilia testing was planned [5].
Protein S and C levels were normal with normal fibrino-
gen level. DRVVT (Dilute russell’s viper venom test) and
KCT (Kaolin clotting time) were negative. Next she was
discharged on warfarin 15 mg once a day. She was
reviewed at the medical clinic in a week and two weeks’
time, and then she had the target INR. In subsequent
clinic visits INR was in the sub therapeutic range (1.2 to
1.6). She had poor drug compliance and clinic follow up
despite proper education of family members as well as
the patient. She refused admission for in ward manage-
ment. She defaulted clinic follow up and for about five
months of initial presentation was admitted to a local
hospital with sudden onset of difficulty in breathing with
low blood pressure. She died a few minutes after admis-
sion. Large pulmonary embolism obstructing the left
pulmonary artery was detected on post mortem
examination.
Discussion
Venous thromboembolism is a rare complication of tu-
berculosis. The association between inflammation,
haemostatic changes and hypercoagulable state has been
established in tuberculosis recently. Another mechanism
of DVT is retroperitoneal adenopathies in patients with
tuberculosis causing compression of the inferior vena
cava in the absence of any haemostatic abnormalities [6].
This is unlikely in our patient as we have excluded ab-
dominal adenopathies by ultrasonographically.
Hypercoagulability in tuberculosis is attributed to de-
creased antithrombin lll and protein C, elevated plasma
fibrinogen level, increased platelet aggregation and react-
ive thrombocytosis [7,8]. Apart from high frequency of
antiphospholipid antibody levels in a patient with tuber-
culosis, deficiency of protein S has been mentioned [8].
But in our patient all these were normal.
Robsen et al. found 35 patients with pulmonary tuber-
culosis with DVT but only two of them, DVT was the
presenting feature as in our case [9]. Some reports indi-
cate that thrombotic phenomena in patients with pul-
monary TB can occur in other sites as well [10,11].
Turken et al. in a case control study demonstrated
haemostatic disturbances in 45 patients with active pul-
monary tuberculosis [8]. It has stated that haemostatic
disturbances improved within four weeks of commencingATT [8]. For this reason, ATT should be started immedi-
ately in addition to anticoagulant treatment. So early com-
mencement of ATT in our patient would have contributed
to the absence of thrombophilic changes, as it was done
after two months of treatment.
This patient who presented with lower limb DVT with
pulmonary tubercolosis did not have any other risk fac-
tors or causes for the development of DVT. Thrombo-
philia screen for protein C, S were negative and she does
not fulfill the criteria for antiphospholipid syndrome or
connective tissue disorders with high risk of DVT. We
could not investigate for the Factor V Leiden mutation
and genetic study for prothrombin gene mutation due to
its unavailability at the time of investigation and finan-
cial constraints.
Our patient was initially started on anticoagulant treat-
ment and the target INR was achieved with a daily war-
farin 7 mg dose. She was started on standard ATT
according to her body weight once diagnosis of pulmon-
ary tuberculosis was made. Then the maintenance of the
target INR was difficult and a high dose of warfarin
(15 mg daily) was administered to achieve the target
INR. This was explained by hypercoaguability state in-
duced by rifampicin [12] by decreasing hepatic produc-
tion and increasing clearance of anticoagulants. In
addition rifampicin is a cytochrome p450 inducer. Even
after providing proper information on warfarin therapy,
the patient’s drug compliance was poor and she
defaulted in clinic follow up. All these would have con-
tributed to her succumbing to pulmonary embolism.
Apart from DVT, our patient clinical picture was com-
plicated with co-existent Mycoplasma infection. This
was evident by initial deterioration of the chest X-ray
with minimal respiratory signs and symptoms with rising
Mycoplasma antibody titer.
Even though this patient was anemic it was unlikely to
be due to mycoplasma induced hemolytic anemia as she
had normal bilirubin levels, with normal retic count &
negative Coombs test. She was from a poor socioeco-
nomic background and had hypochromic microcytic
anemia suggesting iron deficiency with menorrhagia.
Iron supplement was given and her haemoglobin and
blood picture was improved. Serum iron studies were
not done due to financial constrains.
Conclusion
Our case emphasizes that patients with severe pulmon-
ary tuberculosis are at risk of developing thromboembol-
ism due to the disease itself. Therefore clinicians should
have high index of suspicion to diagnose these cases. It
should be noted that even though starting ATT itself im-
proves haemostatic disturbances, achieving target INR is
difficult due to drug interactions. Thus they should be
followed up closely to prevent complication and death
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should keep in mind that pulmonary tuberculosis pa-
tients can develop superadded infections as well.
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